Nuwintore 1

Five years after his diagnosis, Richard Nuwintore still swallows four pills a day of the potent antifungal itraconazole.

Richard Nuwintore was barely three weeks into his sentence at Taft Correctional Institution when he began to cough and experience chest pain. Within a few days, it was obvious something was wrong.

“I could touch my skin and I was really hot,” Nuwintore said. “I had the coughing, the night sweat. My appetite was gone. I couldn't eat. I couldn't swallow, and I was losing weight really, really fast.”

A diagnosis arrived after X-rays and blood tests: valley fever, a fungal disease endemic to dusty areas of California and Arizona. Kern County, where Taft is located, has the highest rate of valley fever cases of any county in California. Originally a refugee from the east African country of Burundi, Nuwintore had never heard of the disease before arriving at Taft.

Nuwintore 2

Originally from the African country of Burundi, Nuwintore keeps this painting to remind him of rural life back at home.

“Other inmates were telling me about valley fever, and I was like, ‘What is it? What is it?’” he said. “It was something scary, you know?”

Nuwintore was a victim of climate, genetics and confinement. In 2011, when he was diagnosed, valley fever rates in Arizona and California were skyrocketing — a peak experts largely attribute to weather cycles of rain and drought. And research shows people of African-American or African descent, like Nuwintore, are more prone to the disease than Caucasians.

At that time, valley fever rates were particularly high within prisons in the Central Valley. State prisons there reported hundreds of cases and as many as nine deaths from valley fever every year. In the hardest hit prison in 2011, 7 percent of the inmates contracted the disease. Taft is a federal prison and its health data have not been made available.

In the last few years, state prisons, at least, have made changes. They have worked harder to screen out prisoners who are the most vulnerable to the disease and to take measures to lower the risk to inmates who are incarcerated there. Between 2011 and 2015, their valley fever rates fell dramatically — close to 90 percent overall. Within that time period, valley fever became less prevalent all around, but even in the most endemic areas of the southwest, background rates fell by only 30 to 50 percent.


Nuwintore came to the U.S. as a refugee in 1992. In 2011, he began a 14-month prison sentence for credit card fraud. Now, he lives on a suburban cul-de-sac outside Sacramento with his mother and girlfriend.

Years after completing his sentence, Nuwintore’s time in prison remains in his system. Twice a day, he twists open a thick bottle of itraconazole, an antifungal medication that he’ll likely take for the rest of his life. The huge pink and blue pills keep him alive, but their side effects are almost as bad as valley fever itself.

“You wake up. You have a little bit of energy, but as the day goes by you start to just feel pain in the joints,” he said. “Of course, your stomach is still on fire because the medicine is kind of powerful. And fatigue, and sometimes you get dizzy.”

Nuwintore isn’t alone. In the last decade, more than 3,500 state inmates have contracted valley fever while doing time. Many still struggle to manage the disease.


Between 2007 and 2015, almost 3,500 state prisoners in California were diagnosed with valley fever. Pleasant Valley State Prison in western Fresno County has reported the most cases of valley fever of any California state prison.


Those improvements in state prisons did not happen quickly or easily. In fact, it took outside intervention to bring the numbers down.

Beginning in 2006, the California Department of Corrections and Rehabilitation began excluding inmates with suppressed immune systems — due to factors such as HIV or chemotherapy — from all eight prisons in the Central Valley. But valley fever rates still spiked.

More sweeping interventions arrived in 2013. That’s when a federal receiver appointed to oversee health care in state prisons mandated that individuals from the most at-risk ethnicities — African Americans and Filipinos — be excluded from Avenal State Prison in Kings County and Pleasant Valley State Prison in Fresno County. Prior to that year, those two facilities each diagnosed hundreds more cases of valley fever annually than almost any other state prison.

“I think [valley fever] is one of the biggest issues that we've had in this system,” said Janet Mohle-Boetani, a health administrator with the California Department of Corrections and Rehabilitation. “We're taking precautions for every prison in the Central Valley, and we're taking extra special precautions for the two prisons that have the very high rates of valley fever.”

Those two prisons have also modified their landscaping to minimize dust, and they allow inmates to stay indoors when wind speeds are high. Inmates also are allowed to wear dust masks while they’re outside.

The biggest change arrived in 2015 on the recommendation of the Centers for Disease Control and Prevention. It’s a skin test called Spherusol that can detect valley fever immunity, and it’s offered to every inmate entering the state prison system. An individual who tests positive is immune.

“If they inhale the dust with the fungus in it and they've tested negative, they're much more likely to get the disease than someone who has a positive test,” said Mohle-Boetani. “So if someone comes into the reception center and then they test negative, we put a medical restriction on those patients so they are not sent to live in Avenal or Pleasant Valley State Prison.”

People gain immunity after successfully fighting off the disease — and because so many people are infected without developing symptoms, many people never know they had the disease. In a mass screening in early 2015, around 35,000 inmates in the California prison system took the test and 9 percent were shown to be immune.

The CDC recommended Spherusol to the state prison system shortly after the test became commercially available in 2014. The FDA has not actually approved of using the test for this purpose, but like other medical products, it can be used off-label.

“Given the fact that they were having such high rates of cocci, we knew that we needed to do whatever we could to try to help them lower the risk,” said Tom Chiller, chief of the Mycotic Diseases Branch at the CDC, referring to valley fever by its scientific nickname. “We immediately thought, maybe this could be used to understand which prisoners could exist in an area with the fungal spores but not get infected, or at least have an extremely low risk of getting infected.”


Pleasant Valley State Prison in western Fresno County has reported the most cases of valley fever of any California state prison.

The CDC predicted Spherusol would prevent more valley fever cases than any other measure so far, but Chiller said it’s still too early to calculate the test’s precise impact. Sharing that opinion is Dr. John Galgiani, director of the University of Arizona’s Valley Fever Center for Excellence.

“I think they should be given credit for the drop to some extent, but it'll take time to see if it stays low to see if it's because of the policies that are now put in place,” Galgiani said.

Taft, a federal prison, is a slightly different story. According to a representative from MTC, the company that runs the privately operated prison, incoming inmates are provided with information about valley fever risk, but they are not offered a Spherusol test. The representative did not reveal if at-risk inmates are relocated to other facilities.

Richard Nuwintore may not have the energy to hold down a job, but he has been keeping busy. Earlier this year, he and another Taft inmate won a landmark court case that granted inmates who contract the disease in federal prison the right to sue the U.S. government. Lawsuits have been filed against the state prison system for years.

It’s one path of recourse for Californians who do their time and come out with a life sentence.

(4) comments


Yes, my wife was diagnosed with Valley Fever the first summer we spent here in the valley. Coincidentally, that was 2011. The extremely expensive medications, with nasty side effects, didn't help much, and they told her she would have it forever most likely. Good thing I have experience with Colloidal Silver. Put it in the humidifier of her C-Pap machine, and killed it fairly quickly. Not to mention inexpensively. The medical profession really doesn't like anything that we can make or grow on our own.

gary chandler

What's the connection between infectious waste and Valley Fever? It's time to stop the dumping of infectious waste on land. Tons of infectious, toxic and radioactive sewage sludge are being dumped throughout this region every year. Valley fever is much more than just the cocci fungus. It's time to enforce the Bioterrorism Preparedness and Response Act of 2002 to protect public health.


Shocking, a refugee from a third world country showing how grateful he is to be given the great opportunity repays us by running a credit card scam and costing us more money. Goes to prison costing us more money gets valley fever like most of us who live here and work here and he gets the best health care possible we are paying for. The writer forgot to include his prescription is being paid for by us and the disability check he gets every month is on us. Welcome to America and California have some free taxpayer earned money.


Okay, I'll ask. Why hasn't the Federal Government put this felon back on a plane to Africa where he belong?

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.